| Literature DB >> 32270957 |
Orhan Gokalp1, Levent Yilik1, Hasan Iner1, Nihan Karakas Yesilkaya1, Yuksel Besir1, Sahin Iscan2, Bortecin Eygi2, Ali Gurbuz1.
Abstract
INTRODUCTION: One of the most important points of the acute type A aortic dissection surgery is how to perform cannulation regarding cerebral protection concerns and the conditions of arterial structures as a pathophysiological consequence of the disease.Entities:
Keywords: Aneurysm; Catheterization; Dissecting; Surgeons; Vascular Surgical Procedures
Mesh:
Year: 2020 PMID: 32270957 PMCID: PMC7089736 DOI: 10.21470/1678-9741-2018-0354
Source DB: PubMed Journal: Braz J Cardiovasc Surg ISSN: 0102-7638
Preoperative data.
| Femoral cannulation | Axillary cannulation | |||||||
|---|---|---|---|---|---|---|---|---|
| Mean±sd/n-% | Med | Mean±sd/n-% | Med | |||||
| Age | 58.3±13.7 | 62.0 | 52.5±15.1 | 55 | 0.163t | |||
| Gender | Female | 9 | 16 | 0.376X2 | ||||
| Male | 13 | 14 | ||||||
| DM | 2 | 9 | 0.068X2 | |||||
| COPD | 6 | 7 | 0.746X2 | |||||
| Smoking | 14 | 16 | 0.458X2 | |||||
| CRF | 2 | 0 | 0.181X2 | |||||
| HT | 15 | 23 | 0.496X2 | |||||
| Aortic diameter (mm) | 54.1±12.2 | 52.5 | 53 | 0.690m | ||||
| Marfan | 3 | 4 | 0.975X2 | |||||
| BSA | 1.8±0.2 | 1.8 | 1.8±0.1 | 1.8 | 0.554t | |||
| Repeat surgery | 7 | 5 | 0.200X2 | |||||
| EuroSCORE | 4.6±1.4 | 4.0 | 4.6±1.5 | 5 | 0.828m | |||
| CPR | 2 | 0 | 0.174X2 | |||||
| Tamponade or effusion | 8 | 8 | 0.454X2 | |||||
| Hemoglobin (g/dL) | 11.4±1.9 | 11.8 | 11.6±1.7 | 11.4 | 0.690t | |||
| WBC >11.000 (K/uL) | 15 | 15 | 0.190X2 | |||||
| EF <50 | 8 | 9 | 0.629X2 | |||||
t: t test; m: Mann-Whitney U test; X: Chi-square test (Fisher's test).
BSA=body surface area; COPD=chronic obstructive pulmonary disease; CRF=chronic renal failure; CPR=cardiopulmonary resuscitation; DM=diabetes mellitus; EF=ejection fraction; HT=hypertension; WBC=white blood cells
Perioperative data.
| Femoral cannulation | Axillary cannulation | ||||||
|---|---|---|---|---|---|---|---|
| Mean±sd/n-% | Med | Mean±sd/n-% | Med | ||||
| CPB time (min) | 195.0±28.2 | 199 | 196.5±31.4 | 193 | 0.476m | ||
| Cross-clamp time (min) | 133.3±23.3 | 134.5 | 132.4±19.6 | 133.5 | 0.897m | ||
| Operating time (min) | 318.2±35 | 320.5 | 332.0±74.8 | 325 | 0.610m | ||
| Root intervention | 7 | 9 | 0.888X2 | ||||
| Hemiarch intervention | 7 | 5 | 0.200X2 | ||||
| Total arch intervention | 1 | 5 | 0.176X2 | ||||
| Only ascending aortic intervention | 7 | 12 | 0.545X2 | ||||
| ACP | 13 | 30 | |||||
| ACP time (min) | 37.8±16.5 | 35 | 40.4±14.9 | 38.5 | 0.347m | ||
| TCA | 13 | 22 | 0.279X2 | ||||
| TCA time (min) | 39.5±5.4 | 39 | 38.8±4.7 | 40 | 0.864m | ||
| Weaning time (h) | 23.3±8.4 | 25 | 21.6±15.4 | 18 | 0.169m | ||
| ICU time (days) | 7.5±7.1 | 5 | 6.4±4.6 | 5 | 0.804m | ||
| Hospital discharge time (days) | 13.6±10.7 | 9 | 11.7±5.6 | 10 | 0.678m | ||
| Postoperative drainage (ml) | 835.7±388.3 | 800 | 813.3±380.1 | 750 | 0.759m | ||
| Blood product (IU) | 4.7±2.8 | 4 | 4.8±2.8 | 5 | 0.866m | ||
| POAKI | 8 | 6 | 0.189X2 | ||||
| Reoperation for bleeding | 7 | 9 | 0.888X2 | ||||
| Prolonged intubation | 10 | 12 | 0.584X2 | ||||
| Neurological complication | 5 | 6 | 0.812X2 | ||||
| Mortality | 3 | 3 | 0.685X2 | ||||
m: Mann-Whitney U test; X2: Chi-square test (Fisher's test).
ACP=antegrade cerebral perfusion; CPB=cardiopulmonary bypass; ICU=intensive care unit; POAKI=postoperative acute kidney injury; TCA=total circulatory arrest
| Abbreviations, acronyms & symbols | |
|---|---|
| ACP | = Antegrade cerebral perfusion |
| ASA | = American Society of Anesthesiologists |
| ATAAD | = Acute type A aortic dissection |
| CBP | = Cardiopulmonary bypass |
| CC | = Cross-clamp |
| CT | = Computed tomography |
| EJCTS | = European Journal of Cardiothoracic Surgery |
| EuroSCORE | = European System for Cardiac Operative Risk Evaluation |
| MACCEs | = Major adverse cardiac and cerebrovascular events |
| ICU | = Intensive care unit |
| ICVTS | = Interactive Cardiovascular and Thoracic Surgery |
| TCA | = Total circulatory arrest |
| Author's roles & responsibilities | |
|---|---|
| OG | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published |
| LY | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published |
| HI | Acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |
| NKY | Acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |
| YB | Acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |
| SI | Acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |
| BE | Acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |
| AG | Acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published |